Richard S. Levy, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 5,000 shares at $350.00 ($1.8M) on 2024-11-07, disclosed to the SEC on 2024-11-08.
Scheduled sale ($1.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TARA | BUY | 2025-05-19 | $64K | — | Filing → |
| MDGL | SELL | 2024-11-05 | $2.7M | — | Filing → |
| MDGL | SELL | 2024-04-03 | $4.1M | — | Filing → |